Literature DB >> 18236732

Managing diabetes in the elderly: go easy, individualize.

Thomas Hornick1, David C Aron.   

Abstract

The care of elderly patients with diabetes should be individualized, taking into account the patient's comorbidities, other medications, cognitive abilities, home care situation, and life expectancy. Especially in frail, elderly patients, there should be less emphasis on strict glycemic control than on avoiding malnutrition and hypoglycemia and achieving the best quality of life possible.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18236732     DOI： 10.3949/ccjm.75.1.70

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  6 in total

1.  Primary care and health outcomes among older patients with diabetes.

Authors:  Julia C Prentice; B Graeme Fincke; Donald R Miller; Steven D Pizer
Journal:  Health Serv Res       Date:  2011-08-22       Impact factor: 3.402

2.  Genetic determinants predicting efficacy of glucose-lowering drugs?: a long way to go ...

Authors:  Michael A Nauck; Irfan Vardarli
Journal:  Diabetes Care       Date:  2010-09       Impact factor: 17.152

3.  Management of hyperglycemia in geriatric patients with diabetes mellitus: South Asian consensus guidelines.

Authors:  Manash P Baruah; Sanjay Kalra; Ambika Gopalkrishnan Unnikrishnan; Syed Abbas Raza; Noel Somasundaram; Mathew John; Prasad Katulanda; Dina Shrestha; Ganpathy Bantwal; Rakesh Sahay; Tint Swe Latt; Faruque Pathan
Journal:  Indian J Endocrinol Metab       Date:  2011-04

4.  A Post Hoc Analysis of HbA1c, Hypoglycemia, and Weight Change Outcomes with Alogliptin vs Glipizide in Older Patients with Type 2 Diabetes.

Authors:  Morgan Bron; Craig Wilson; Penny Fleck
Journal:  Diabetes Ther       Date:  2014-11-26       Impact factor: 2.945

Review 5.  Diabetes mellitus in elderly.

Authors:  Farida Chentli; Said Azzoug; Souad Mahgoun
Journal:  Indian J Endocrinol Metab       Date:  2015 Nov-Dec

6.  Long-term safety and tolerability of saxagliptin add-on therapy in older patients (aged ≥ 65 years) with type 2 diabetes.

Authors:  Nayyar Iqbal; Elsie Allen; Peter Öhman
Journal:  Clin Interv Aging       Date:  2014-09-04       Impact factor: 4.458
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.